Nationwide Laboratories, LLC

FDA Regulatory Profile

Nationwide Laboratories, LLC appears in FDA public data with 4 recalls, 0 510(k) clearances, 2 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0167-2017, Class II) was initiated on October 28, 2016.

Summary

Total Recalls
4
510(k) Clearances
0
Inspections
2
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0167-2017Class IIPhenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: NaOctober 28, 2016
D-0166-2017Class IISalsalate Tablets, USP, 750 mg, packaged in a) 100 count bottles (NDC 42937-704-10); b) 500 count boOctober 28, 2016
D-0168-2017Class IIPhenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: NaOctober 28, 2016
D-0165-2017Class IISalsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count boOctober 28, 2016